Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System

Completed

Conditions studied: Diabetes Mellitus

In brief

This is a prospective, non-randomized, observational study conducted in the United States.Up to sixty (60) subjects will be enrolled. The purpose of the study is to evaluate long-term utility and usability of Dexcom G4 Continuous Glucose Monitoring (CGM) System. Subjects will be followed monthly over a period of one year.

Key facts

Study ID

NCT01627210

Run by

DexCom, Inc.

People needed

60

Starts

2012-05-01

Expected to finish

2012-12-01

Last updated by the study team

2013-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Require intensive insulin therapy, defined as use of Continuous Subcutaneous Insulin Infusion (CSII) i.e. insulin pumps or multiple daily injections (MDI.
• Willing to refrain from use of any acetaminophen - containing (ACT) medication during the study, up to 24-hours before the initial sensor insertion.

You may not qualify if…

• Have extensive skin changes/ diseases that preclude wearing the device.
• Dialysis.

Where it is running

• Catalina Research Institute — Chino, California, United States
• Diabetes and Endocrine Associate — La Mesa, California, United States
• Infosphere — West Hills, California, United States
• Desert Endocrinology Clinical Research Center — Henderson, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.